Corrigendum to “Identification of LIMK2 as a therapeutic target in castration resistant prostate cancer” [Cancer Lett 448 (2019)182–196, (S0304383519300552), (10.1016/j.canlet.2019.01.035)]
Authors: Kumar Nikhil; Lei Chang; Keith Viccaro; Max Jacobsen; Callista McGuire; Shakti R. Satapathy; Michael Tandiary; Meaghan M. Broman; Gregory Cresswell; Yizhou J. He; George E. Sandusky; Timothy L. Ratliff; Dipanjan Chowdhury; Kavita Shah
Corrigendum to “Negative cross talk between LIMK2 and PTEN promotes castration resistant prostate cancer pathogenesis in cells and in vivo”(Cancer Letters, (2021), 498, C, (1-18), (S0304383520304729), 10.1016/j.canlet.2020.09.010)
Authors: Kumar Nikhil; Mohini Kamra; Asif Raza; Kavita Shah
Correction: Phosphorylation-dependent regulation of SPOP by LIMK2 promotes castration-resistant prostate cancer (British Journal of Cancer, (2021), 124, 5, (995-1008), 10.1038/s41416-020-01197-6)